BITF Bitfarms Ltd. - Fundamental Analysis
At a glance
Key valuation, profitability, growth, and risk metrics.
AI Analysis
Powered by advanced machine learning algorithms
Key Strengths
Key Risks
Performance Snowflake
Multi-dimensional analysis across 5 key categories
Ref P/E, PEG, Graham Number
- Forward P/E of -68.50 indicates no earnings support
- Price/Sales of 5.93 is extremely high for an unprofitable company
- No Graham Number or Intrinsic Value available due to negative earnings
Ref Growth rates
- Revenue growth of 155.80% YoY is exceptional
- Analyst target implies significant upside
- Earnings growth is negative (YoY EPS change: -87.5%)
- Q/Q EPS decline of -200.0% shows accelerating deterioration
- No visibility on profitability inflection
Ref Historical trends
- 6M price return of +122.8% shows strong recent performance
- 20 out of 21 quarters missed or underperformed earnings estimates
- Long history of negative surprises including -1900% in 2022
- Persistent unprofitability over multiple years
Ref Altman Z-Score, Piotroski F-Score
- Current ratio of 3.20 provides short-term liquidity cushion
- Debt/Equity of 0.12 is very low, reducing solvency risk
- Piotroski F-Score of 0/9 indicates critical financial weakness
- ROA of -8.17% and ROE of -12.50% show poor asset and equity efficiency
- Gross margin of only 4.61% limits operating flexibility
Ref Yield, Payout
- Dividend Strength score of 0/100
- No dividend yield or payout history
- No indication of future dividend plans
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Multi-Horizon Performance vs Peers
Price momentum across 5Y → 1W horizons for BITF and closest competitors.
| Company | 5Y | 3Y | 1Y | 6M | 1M | 1W |
|---|---|---|---|---|---|---|
|
BITF
Bitfarms Ltd.
Primary
|
+20.7% | +142.5% | +70.2% | +122.8% | +2.6% | -7.1% |
|
BSTZ
BlackRock Science and Technology Term Trust
Peer
|
+4.5% | +76.4% | +17.1% | +13.7% | -0.8% | -0.1% |
|
BDJ
BlackRock Enhanced Equity Dividend Trust
Peer
|
+74.8% | +37.0% | +19.0% | +12.5% | +2.6% | +0.9% |
|
BMEZ
BlackRock Health Sciences Term Trust
Peer
|
-15.2% | +31.8% | +7.0% | +16.6% | +2.9% | +1.9% |
|
BLX
Banco Latinoamericano de Comercio Exterior, S. A.
Peer
|
+299.4% | +227.1% | +29.8% | +12.0% | +5.6% | +3.8% |
Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.
Historical Performance Trends
Long-term financial metrics and growth patterns
Revenue & Net Income
Profit & Operating Margins
Return on Equity (ROE)
Quarterly Revenue Growth
Valuation Metrics
Key valuation ratios and pricing indicators
Profitability
Profit margins and return metrics
Growth
Revenue and earnings growth rates
Financial Health
Balance sheet strength and liquidity metrics
Quarterly Earnings History
EPS performance vs analyst estimates
Financial Services Sector Comparison
Similar Companies
Peer comparison within the same industry
| Company | AI Rating | Market Cap | P/E | ROE | Profit Margin | Price | |
|---|---|---|---|---|---|---|---|
|
BITF
Bitfarms Ltd.
|
BEARISH | $1.64B | - | -12.5% | -46.4% | $2.74 | |
|
BSTZ
BlackRock Science and...
|
BEARISH | $1.6B | 3.64 | -% | -% | $22.64 | |
|
BDJ
BlackRock Enhanced Equity...
|
NEUTRAL | $1.68B | 9.79 | 10.3% | 384.9% | $9.5 | |
|
BMEZ
BlackRock Health Sciences...
|
BEARISH | $1.57B | - | -% | -% | $15.54 | |
|
BLX
Banco Latinoamericano de...
|
NEUTRAL | $1.72B | 7.9 | 15.0% | 72.1% | $46.76 |
Wall Street Analysts
Professional analyst ratings and price targets
Past News Coverage
Recent headlines mentioning BITF from our newsroom.